Menarini Biotech is a CDMO specializing in process development and GMP manufacturing of biopharmaceuticals in diverse therapeutic areas. Established in 2003, the company provides fast, efficient, customer-centric, high-quality services for biotech companies from preclinical development to GMP manufacturing (both mammalian and microbial). These services include CHO cell line and analytical development for both standard and nonstandard mAbs, as well as for novel molecular formats such as bispecifics, ADCs, and fusion proteins. Menarini Biotech is based outside of Rome, and is a division of the Menarini Group, which dates back to 1886.